Marie V. Nelson
Pediatric Hematology Oncology
3571 West 13 Mile Road
Floor 2
Royal Oak, MI 48073
Floor 2
Royal Oak, MI 48073
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Trained autologous cytotoxic T-cells derived from PBMCs or splenocytes for immunotherapy of neuroblastoma.
Journal: Frontiers in immunology
Published: December 16, 2024
Phase II study of vemurafenib in children and young adults with tumors harboring BRAF V600 mutations: NCI-COG pediatric MATCH trial (APEC1621) Arm G.
Journal: The oncologist
Published: April 03, 2024
Understanding Causes of Inferior Outcomes in Adolescents and Young Adults With Cancer.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: March 27, 2023
Current Issues in Fertility Preservation Among Pediatric and Adolescent Cancer Patients.
Journal: Current oncology reports
Published: March 05, 2023
Correction: Targeting the HIF-1α-IGFBP2 axis therapeutically reduces IGF1-AKT signaling and blocks the growth and metastasis of relapsed anaplastic Wilms tumor.
Journal: Oncogene
Published: January 20, 2022
Hepatocellular carcinoma as a complication of Niemann-Pick disease type C1.
Journal: American journal of medical genetics. Part A
Published: March 30, 2021
MYC oncogene is associated with suppression of tumor immunity and targeting Myc induces tumor cell immunogenicity for therapeutic whole cell vaccination.
Journal: Journal for immunotherapy of cancer
Published: February 14, 2021
Targeting the HIF-1α-IGFBP2 axis therapeutically reduces IGF1-AKT signaling and blocks the growth and metastasis of relapsed anaplastic Wilms tumor.
Journal: Oncogene
Published: January 24, 2021
New approaches to risk stratification for Wilms tumor.
Journal: Current opinion in pediatrics
Published: January 04, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026